| 764308 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
254 NTX-1088, a potent anti-PVR Mab induces DNAM1-mediated antitumor immunity |
2021-11-01 |
10.1136/jitc-2021-sitc2021.254 |
Atieh Anas, Obiedat Akram, Cinamon Guy, Rovis Tihana Lenac, Brlic Paola Kucan, Hirsl Lea, Mandelboim Ofer, Jonjic Stipan, Paz Keren, Tsukerman Pini |
| 764307 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
248 Empiric profiling of peripheral T cell recall responses to tumor mutanomes versus in silico predictions in NSCLC patients undergoing pembrolizumab treatment ± chemotherapy |
2021-11-01 |
10.1136/jitc-2021-sitc2021.248 |
Milaszewski Madison, Loizeaux James, Tjon Emily, Cabral Crystal, Dadali Tulin, Strickland Justin, Foti Jamie, Mancini Kevin, Michael Kesi, Dowal Louisa, Vemulapalli Vijetha, Visintin Alberto, Davis Thomas, Flechtner Jessica, Awad Mark |
| 764306 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
244 Genomic determinants of response to chemoradiation and durvalumab consolidation for stage III non-small cell lung cancer |
2021-11-01 |
10.1136/jitc-2021-sitc2021.244 |
Guo Matthew, Murray Joseph, Ghanem Paola, Voong Khinh Ranh, Hales Russell, Feliciano Josephine, Marrone Kristen |
| 764305 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
225 Optimal-affinity MAGE-A1-specific T cell receptors (TCRs) generated using the humanized TCR-transgenic mouse platform HuTCR are superior to human donor-derived TCRs |
2021-11-01 |
10.1136/jitc-2021-sitc2021.225 |
Gavvovidis Ioannis, Leisegang Matthias, Scheuplein Vivian, Obenaus Matthias, Blankenstein Thomas, Kieback Elisa |
| 764304 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
223 Potent inhibition of PI3Kδ promotes enhanced T cell stemness and mitochondrial fitness |
2021-11-01 |
10.1136/jitc-2021-sitc2021.223 |
RIvera Guillermo Rangel, Dwyer Connor, Knochelmann Hannah, Smith Aubrey, Cole Anna, Wyatt Megan, Ware Brandon, Paulos Chrystal |
| 764303 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
73 Characterization of tumor-infiltrating T-cell repertoire in human cancers |
2021-11-01 |
10.1136/jitc-2021-sitc2021.073 |
Harding Taylor, Yang Qidi, Mineo Brittany, Malinauskas Jenna, Perera Jason, Beutner Karl, Lau Denise, Khan Aly |
| 764302 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
317 An immunosuppressive tumor population drives global and regional patterns of immune infiltration in heterogeneous tumors |
2021-11-01 |
10.1136/jitc-2021-sitc2021.317 |
Tanaka Miho, Lum Lotus, Ng Kenneth, Adams Zoe, Superville Daphne, Reeves Melissa |
| 764301 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Subject index |
2021-11-01 |
10.1136/jitc-2021-sitc2021.subjectindex |
|
| 764300 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Author index |
2021-11-01 |
10.1136/jitc-2021-sitc2021.authorindex |
|
| 764299 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
962 Integrative immunomics highlight the immunomodulatory impact of neoadjuvant chemotherapy and immune-based treatments in resected non-small-cell lung cancer |
2021-11-01 |
10.1136/jitc-2021-sitc2021.962 |
Schmidt Stephanie, Lee Younghee, Leung Cheuk, Federico Lorenzo, Lin Heather, Weissferdt Annikka, Pataer Apar, Dejima Hitoshi, Francisco-Cruz Alejandro, Rojas Frank, Solis Luisa, Parra Edwin, Pradhan Monika, Guo Haiping, William William, Reuben Alexandre, Kadara Humam, Wistuba Ignacio, Zhang Jianjun, Swisher Stephen, Vaporciyan Ara, Negrao Marcelo, Bristow Christopher, Heffernan Timothy, Bernatchez Chantale, Lee Jack, Heymach John, Sepesi Boris, Gibbons Don, Haymaker Cara, Cascone Tina |
